1 Institute of Brain and Behavior, Department of Psychiatry, University of Maastricht, Maastricht, The Netherlands 2 Department of Radiology, Academisch Ziekenhuis Maastricht, Maastricht, The ...

Correspondence to Dr Laura McWhirter, Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh EH16 4SB, UK; laura.mcwhirter{at}ed.ac.uk Background The term ‘brain fog’ is ...

Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...

1 Department of Neurology, Westmead Hospital and Western Clinical School, University of Sydney, Sydney, Australia 2 Prince of Wales Medical Research Institute and Prince of Wales Clinical School, ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting the upper and lower motor neurons. A key clinical feature of ALS is the absence of accurate, early-stage ...

Objectives We aimed to compare the long-term outcomes and surgical benefits between moyamoya disease (MMD) and atherosclerosis-associated moyamoya vasculopathy (AS-MMV) using high-resolution MRI ...

Background GBA variants increase the risk of developing Parkinson disease (PD) and influence its outcome. Deep brain stimulation (DBS) is a recognised therapeutic option for advanced PD. Data on DBS ...

Correspondence to: Dr E H Reynolds, Institute of Epileptology, Weston Education Centre, King's College Denmark Hill Campus, Cutcombe Road, London SE5 9PJ, UK During three decades of neurological ...

Correspondence to Dr Timothy Rittman, Department of Clinical Neurosciences, University of Cambridge, Herchel Smith Building, Forvie Site, Addenbrooke's Hospital Site, Robinson Way, Cambridge CB2 0SZ, ...

Correspondence to: Dr Peter Henningsen, Department of Psychosomatic Medicine, University Hospital, Thibautstr 2, 69115 Heidelberg, Germany; peter_henningsen{at}med.uni-heidelberg.de Objective: To ...

Much has been achieved in terms of understanding the complex clinical and genetic heterogeneity of Charcot-Marie-Tooth neuropathy (CMT). Since the identification of mutations in the first CMT ...

Background and purpose Cerebral amyloid angiopathy (CAA) is common in the ageing brain and is associated with dementia and lobar intracerebral haemorrhage. We systematically reviewed genetic ...